Cleared Traditional

ACENT™ Central Venous Catheter (K193158) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
376d
Days
Class 2
Risk

K193158 is an FDA 510(k) clearance for the ACENT™ Central Venous Catheter. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Global Medikit Limited (Dehradun, IN). The FDA issued a Cleared decision on November 24, 2020 after a review of 376 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Global Medikit Limited devices

Submission Details

510(k) Number K193158 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 2019
Decision Date November 24, 2020
Days to Decision 376 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
247d slower than avg
Panel avg: 129d · This submission: 376d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Meditech Consulting
Atonu Dutta

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 138
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K193158.
BD Intima II Closed IV Catheter System, BD Intima II PLUS Closed IV Catheter System
K200891 · Becton, Dickinson and Company · Jun 2021
HydroMID
K203069 · Access Vascular, Inc. · Feb 2021
BD Insyte Autoguard Shielded IV Catheter, BD Insyte Autoguard BC Shielded IV Catheter, BD Insyte Autoguard BC Pro Shielded IV Catheter
K201075 · Becton, Dickinson and Company · Dec 2020
BD Cathena Safety IV Catheter
K201717 · Becton Dickinson Infusion Therapy Systems, Inc. · Sep 2020
Deltaven Fast Flash Closed I.V. Catheter Systems
K200373 · Delta Med Spa · Aug 2020
MedSource CathMED IV Catheter
K193278 · Medsource Labs · Aug 2020